Quantitative LC-MS/MS analysis of arachidonoyl amino acids in mouse brain with treatment of FAAH inhibitor

Analytical Biochemistry

Volumn 432, Issue 2, 2013, Pages 74-81

  Han, Bingnan ^a,b   Wright, Rachel ^a   Kirchhoff, Aaron M ^a   Chester, Julia A ^a   Cooper, Bruce R ^a   Davisson, Vincent Jo ^a   Barker, Eric ^a  

^a PURDUE UNIVERSITY   (United States)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

2 Arachidonoyl glycerol; Anandamide; Arachidonoyl amino acids; Brain; FAAH inhibitor; LC MS MS

Indexed keywords

AMIDES; BRAIN; GLYCEROL;

2-ARACHIDONOYL GLYCEROLS; ANANDAMIDE; CONCENTRATION RANGES; FAAH INHIBITOR; GAMMA-AMINOBUTYRIC ACIDS; LC-MS/MS; PHARMACOLOGICAL EFFECTS; SYSTEMIC ADMINISTRATION;

AMINO ACIDS;

4 AMINOBUTYRIC ACID; ALANINE; ANANDAMIDE; ARACHIDONOYL COENZYME A; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; GLYCINE; SERINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; CONTROLLED STUDY; DOSE RESPONSE; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ARA;

EID: 84868677898     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2012.09.031     Document Type: Article

References (43)

1. T. Bisogno, N. Sepe, D. Melck, S. Maurelli, L. De Petrocellis, and V. Di Marzo Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells Biochem. J. 322 Pt 2 1997 671 677
2. M.P. Patricelli, and B.F. Cravatt Proteins regulating the biosynthesis and inactivation of neuromodulatory fatty acid amides Vitam. Horm. 62 2001 95 131
3. M.L. Yates, and E.L. Barker Inactivation and biotransformation of the endogenous cannabinoids anandamide and 2-arachidonoylglycerol Mol. Pharmacol. 76 2009 11 17
4. V. Di Marzo, A. Fontana, H. Cadas, S. Schinelli, G. Cimino, J.C. Schwartz, and D. Piomelli Formation and inactivation of endogenous cannabinoid anandamide in central neurons Nature 372 1994 686 691
5. A. Fontana, V. Di Marzo, H. Cadas, and D. Piomelli Analysis of anandamide, an endogenous cannabinoid substance, and of other natural N-acylethanolamines Prostaglandins Leukot. Essent. Fatty Acids 53 1995 301 308
6. S.M. Huang, T. Bisogno, T.J. Petros, S.Y. Chang, P.A. Zavitsanos, R.E. Zipkin, R. Sivakumar, A. Coop, D.Y. Maeda, L. De Petrocellis, S. Burstein, V. Di Marzo, and J.M. Walker Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain J. Biol. Chem. 276 2001 42639 42644
7. B. Tan, H.B. Bradshaw, N. Rimmerman, H. Srinivasan, Y.W. Yu, J.F. Krey, M.F. Monn, J.S. Chen, S.S. Hu, S.R. Pickens, and J.M. Walker Targeted lipidomics: discovery of new fatty acyl amides AAPS J. 8 2006 E461 E465
8. J.M. Walker, J.F. Krey, J.S. Chen, E. Vefring, J.A. Jahnsen, H. Bradshaw, and S.M. Huang Targeted lipidomics: fatty acid amides and pain modulation Prostaglandins Other Lipid Mediat. 77 2005 35 45
9. M. Connor, C.W. Vaughan, and R.J. Vandenberg N-acyl amino acids and N-acyl neurotransmitter conjugates: neuromodulators and probes for new drug targets Br. J. Pharmacol. 160 2010 1857 1871
10. G. Barbara, A. Alloui, J. Nargeot, P. Lory, A. Eschalier, E. Bourinet, and J. Chemin T-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids J. Neurosci. 29 2009 13106 13114
11. A.L. Wiles, R.J. Pearlman, M. Rosvall, K.R. Aubrey, and R.J. Vandenberg N-arachidonyl-glycine inhibits the glycine transporter, GLYT2a J. Neurochem. 99 2006 781 786
12. M. Oz Receptor-independent actions of cannabinoids on cell membranes: focus on endocannabinoids Pharmacol. Ther. 111 2006 114 144
13. G. Milman, Y. Maor, S. Abu-Lafi, M. Horowitz, R. Gallily, S. Batkai, F.M. Mo, L. Offertaler, P. Pacher, G. Kunos, and R. Mechoulam N-arachidonoyl L-serine, an endocannabinoid-like brain constituent with vasodilatory properties Proc. Natl. Acad. Sci. USA 103 2006 2428 2433
14. H.B. Bradshaw, N. Rimmerman, J.F. Krey, and J.M. Walker Sex and hormonal cycle differences in rat brain levels of pain-related cannabimimetic lipid mediators Am. J. Physiol. Regul. Integr. Comp. Physiol. 291 2006 R349 R358
15. S.S. Hu, H.B. Bradshaw, V.M. Benton, J.S. Chen, S.M. Huang, A. Minassi, T. Bisogno, K. Masuda, B. Tan, R. Roskoski Jr., B.F. Cravatt, V. Di Marzo, and J.M. Walker The biosynthesis of N-arachidonoyl dopamine (NADA), a putative endocannabinoid and endovanilloid, via conjugation of arachidonic acid with dopamine Prostaglandins Leukot. Essent. Fatty Acids 81 2009 291 301
16. H.B. Bradshaw, N. Rimmerman, S.S. Hu, V.M. Benton, J.M. Stuart, K. Masuda, B.F. Cravatt, D.K. O'Dell, and J.M. Walker The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways BMC Biochem. 10 2009 14
17. A. Minkkila, S. Saario, and T. Nevalainen Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors Curr. Top. Med. Chem. 10 2010 828 858
18. D. Parolaro, N. Realini, D. Vigano, C. Guidali, and T. Rubino The endocannabinoid system and psychiatric disorders Exp. Neurol. 224 2010 3 14
19. B. Tan, D.K. O'Dell, Y.W. Yu, M.F. Monn, H.V. Hughes, S. Burstein, and J.M. Walker Identification of endogenous acyl amino acids based on a targeted lipidomics approach J. Lipid Res. 51 2010 112 119
20. D. Richardson, C.A. Ortori, V. Chapman, D.A. Kendall, and D.A. Barrett Quantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography-tandem electrospray ionization mass spectrometry Anal. Biochem. 360 2007 216 226
21. S. Kathuria, S. Gaetani, D. Fegley, F. Valino, A. Duranti, A. Tontini, M. Mor, G. Tarzia, G. La Rana, A. Calignano, A. Giustino, M. Tattoli, M. Palmery, V. Cuomo, and D. Piomelli Modulation of anxiety through blockade of anandamide hydrolysis Nat. Med. 9 2003 76 81
22. G.D. Barrenha, and J.A. Chester Genetic correlation between innate alcohol preference and fear-potentiated startle in selected mouse lines Alcohol Clin. Exp. Res. 31 2007 1081 1088
23. M.G. Balvers, K.C. Verhoeckx, and R.F. Witkamp Development and validation of a quantitative method for the determination of 12 endocannabinoids and related compounds in human plasma using liquid chromatography-tandem mass spectrometry J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 877 2009 1583 1590
24. J. Williams, J. Wood, L. Pandarinathan, D.A. Karanian, B.A. Bahr, P. Vouros, and A. Makriyannis Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS Anal. Chem. 79 2007 5582 5593
25. D. Schreiber, S. Harlfinger, B.M. Nolden, C.W. Gerth, U. Jaehde, E. Schomig, J. Klosterkotter, A. Giuffrida, G. Astarita, D. Piomelli, and F. Markus Leweke Determination of anandamide and other fatty acyl ethanolamides in human serum by electrospray tandem mass spectrometry Anal. Biochem. 361 2007 162 168
26. T.H. Marczylo, P.M. Lam, A.A. Amoako, and J.C. Konje Anandamide levels in human female reproductive tissues: solid-phase extraction and measurement by ultraperformance liquid chromatography tandem mass spectrometry Anal. Biochem. 400 2010 155 162
27. A. Thomas, G. Hopfgartner, C. Giroud, and C. Staub Quantitative and qualitative profiling of endocannabinoids in human plasma using a triple quadrupole linear ion trap mass spectrometer with liquid chromatography Rapid Commun. Mass Spectrom. 23 2009 629 638
28. A.A. Zoerner, F.M. Gutzki, S. Batkai, M. May, C. Rakers, S. Engeli, J. Jordan, and D. Tsikas Quantification of endocannabinoids in biological systems by chromatography and mass spectrometry: a comprehensive review from an analytical and biological perspective Biochim. Biophys. Acta 2011 1811 706 723
29. E.A. Placzek, B.R. Cooper, A.T. Placzek, J.A. Chester, V.J. Davisson, and E.L. Barker Lipidomic metabolism analysis of the endogenous cannabinoid anandamide (N-arachidonylethanolamide) J. Pharm. Biomed. Anal. 53 2010 567 575
30. E.J. Carrier, C.S. Kearn, A.J. Barkmeier, N.M. Breese, W. Yang, K. Nithipatikom, S.L. Pfister, W.B. Campbell, and C.J. Hillard Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism Mol. Pharmacol. 65 2004 999 1007
31. + coordination tandem mass spectrometry Anal. Biochem. 314 2003 8 15
32. P.M. Lam, T.H. Marczylo, M. El-Talatini, M. Finney, V. Nallendran, A.H. Taylor, and J.C. Konje Ultra performance liquid chromatography tandem mass spectrometry method for the measurement of anandamide in human plasma Anal. Biochem. 380 2008 195 201
33. S. Patel, E.J. Carrier, W.S. Ho, D.J. Rademacher, S. Cunningham, D.S. Reddy, J.R. Falck, B.F. Cravatt, and C.J. Hillard The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity J. Lipid Res. 46 2005 342 349
34. T. Sugiura, S. Kondo, A. Sukagawa, S. Nakane, A. Shinoda, K. Itoh, A. Yamashita, and K. Waku 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain Biochem. Biophys. Res. Commun. 215 1995 89 97
35. D. Piomelli The molecular logic of endocannabinoid signalling Nat. Rev. Neurosci. 4 2003 873 884
36. E.A. Placzek, Y. Okamoto, N. Ueda, and E.L. Barker Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown Neuropharmacology 55 2008 1095 1104
37. B.F. Cravatt, and A.H. Lichtman Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system Curr. Opin. Chem. Biol. 7 2003 469 475
38. K.R. Kozak, and L.J. Marnett Oxidative metabolism of endocannabinoids Prostaglandins Leukot. Essent. Fatty Acids 66 2002 211 220
39. K.R. Kozak, B.C. Crews, J.D. Morrow, L.H. Wang, Y.H. Ma, R. Weinander, P.J. Jakobsson, and L.J. Marnett Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides J. Biol. Chem. 277 2002 44877 44885
40. S.H. Burstein, R.G. Rossetti, B. Yagen, and R.B. Zurier Oxidative metabolism of anandamide Prostaglandins Other Lipid Mediat. 61 2000 29 41
41. J.M. McCue, W.J. Driscoll, and G.P. Mueller Cytochrome c catalyzes the in vitro synthesis of arachidonoyl glycine Biochem. Biophys. Res. Commun. 365 2008 322 327
42. H. Aneetha, D.K. O'Dell, B. Tan, J.M. Walker, and T.D. Hurley Alcohol dehydrogenase-catalyzed in vitro oxidation of anandamide to N-arachidonoyl glycine, a lipid mediator: synthesis of N-acyl glycinals Bioorg. Med. Chem. Lett. 19 2009 237 241
43. S.H. Burstein, J.K. Adams, H.B. Bradshaw, C. Fraioli, R.G. Rossetti, R.A. Salmonsen, J.W. Shaw, J.M. Walker, R.E. Zipkin, and R.B. Zurier Potential anti-inflammatory actions of the elmiric (lipoamino) acids Bioorg. Med. Chem. 15 2007 3345 3355